The purpose of this study is to demonstrate the safety and efficacy of the Alleviate-HF patient management pathway (investigational) which uses as needed medication interventions in subjects with a 'high' heart failure status based upon the risk algorithm data collected by the market-released Reveal Linq device.
Please use this link for further information:
Primary Investigator: Ankit Bhatia